ThermoGenesis Holdings, Inc.

ThermoGenesis Holdings, Inc.

OOTC:THMO
0.00
USD
0.00
(0.00%)
-4.98EPS
Nov 17Next Earn

Important Dates

ThermoGenesis Holdings, Inc.'s next confirmed earnings release is scheduled for November 17, 2026.

Earnings Date11/17/2026

Share Statistics

As of March 31, 2024, ThermoGenesis Holdings, Inc. has 7.95M shares outstanding.

Shares Outstanding7.95M

Financial Position

As of March 31, 2024, ThermoGenesis Holdings, Inc. maintains a current ratio of 0.52, meaning it holds 0.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -637.17, indicating conservative leverage, while an interest coverage ratio of -0.91 demonstrates limited ability to service its debt obligations.

Current Ratio0.52
Quick Ratio0.28
Debt / Equity-637.17
Debt / EBITDA-1.00
Interest Coverage-0.91

Financial Efficiency

USD

Over the twelve months ended March 31, 2024, ThermoGenesis Holdings, Inc. posted a negative return on equity (ROE) of -417.94, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -98.83, reflecting losses generated across the asset base. The company generates approximately 291,212.12 in revenue per employee across its workforce of 33.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.25 indicates how many times ThermoGenesis Holdings, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)-417.94
Return on Assets (ROA)-98.83
Revenue Per Employee291,212.12
Employee Count33.00
Inventory Turnover3.25

Stock Price Statistics

USD

As of the close on October 20, 2026, ThermoGenesis Holdings, Inc.'s stock has gained approximately 0.00% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.08.

200-Day Moving Average0.08

Income Statement

USD

Over the twelve months ended March 31, 2024, ThermoGenesis Holdings, Inc. generated 9.61M in revenue and converted that into -14.74M in net income, yielding earnings per share of -4.98. EBITDA reached -6.91M, while operating income came in at -6.09M.

Revenue9.61M
Gross Profit2.03M
Operating Income-6.09M
Pretax Income-15.74M
Net Income-14.74M
EBITDA-6.91M
EBIT-8.12M
Earnings Per Share (EPS)-4.98

Balance Sheet

USD

As of March 31, 2024, ThermoGenesis Holdings, Inc. holds 1.18M in cash and equivalents against 6.93M in total debt, resulting in a net debt position of 3.03M. Total book value stands at 975,000.00, with working capital of -3.95M providing operational flexibility.

Cash & Cash Equivalents1.18M
Total Debt6.93M
Net Debt3.03M
Equity (Book Value)975,000.00
Book Value Per Share0.12
Working Capital-3.95M

Cash Flow

USD

ThermoGenesis Holdings, Inc. produced -3.61M in operating cash flow over the twelve months ended March 31, 2024.

Operating Cash Flow-3.61M
Free Cash Flow-3.61M
FCF Per Share-1.14

Margins

Over the twelve months ended March 31, 2024, ThermoGenesis Holdings, Inc. posted a gross margin of 21.10, reflecting its pricing power and cost economics. The operating margin of -63.33 and net profit margin of -153.43 provide insight into operational efficiency.

Gross Margin21.10
Operating Margin-63.33
Pretax Margin-163.77
Profit Margin-153.43
EBITDA Margin-71.88

Stock Splits

ThermoGenesis Holdings, Inc.'s most recent stock split took place on December 22, 2022 with a 45:1 split ratio.

Last Split Date12/22/2022
Split Ratio45:1